Home LiteratureArticle Details
PMID: 9541416 Published · ppublish English Journal Article

Hepatitis C status of heart transplant recipients.

Clinical transplantation ·Vol. 12 ·No. 1 ·1998-02-00 ·Pages 5-10

Fagiuoli S, Cooper DK, Zuhdi N

Abstract

The records of 155 consecutive patients who underwent successful heart transplantation (HTx) were reviewed to document the incidence of hepatitis C (HCV) infection. One patient was HCV RNA positive pre-HTx, and 12 patients (8%) developed transient or permanent HCV positivity post-HTx. HCV RNA positivity was associated with biochemical features of liver injury. Liver biopsy was performed in 8, and demonstrated features of chronic hepatitis in all. Two patients died of chronic liver failure at 50 and 56 months post-HTx, respectively. Interferon therapy was given to three patients, two of whom converted to HCV negativity. This study suggests that HCV infection is more common than previously anticipated in HTx patients, and varies from a mild transient condition to a fatal chronic liver failure.

MeSH Terms
Adolescent Adult Aged Enzyme-Linked Immunosorbent Assay Female Heart Transplantation/mortality Hepatitis C, Chronic/diagnosis,epidemiology,mortality Humans Incidence Liver Function Tests Male Middle Aged Polymerase Chain Reaction RNA, Viral/blood RNA-Directed DNA Polymerase
Chemicals
RNA, Viral RNA-Directed DNA Polymerase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Fagiuoli S
Department of Gastroenterology, University of Padua, Italy.
Cooper D K
Zuhdi N
Article Info
Journal
Clinical transplantation
Abbr.
Clin Transplant
ISSN
0902-0063
Published
1998-02-00
Pages
5-10
Language
English
Region
Denmark
NLM ID
8710240
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com